Novartis to Invest in China
BY IAN JOHNSON BEIJING—Novartis AG will spend $1 billion to make China a third global pillar for its research and development, Chief Executive Daniel Vasella said Tuesday. In an interview, Mr. Vasella said China could also... [read full story]
|
RELATED
|
|
Novartis Unveils $1.25 Billion China Investment
Novartis is betting big on China. On Nov. 3, the Swiss pharmaceutical giant announced it plans to invest $1.25 billion in a pair of Chinese R&D centers over the next five years. Novartis will put $250 million into a new R&D...
Novartis To Invest $1 Billion in China R&D Institute
Novartis (Basel, Switzerland) plans to invest $1 billion over the next five years to increase research and development activities in China, including a significant expansion of The Novartis Institute of BioMedical Research...
Novartis to break ground on R&D center in Beijing
By Alaric DeArment BEIJING (Nov. 4) Novartis will spend $1 billion to build the largest pharmaceutical research and development institute in China, the company announced. The Swiss drug maker said the Novartis Institute of...
Novartis Announces New Investment in China to Increase R&D Activities
Swiss pharmaceutical giant Novartis announced on Tuesday that it would invest 1 billion U.S. dollars in China over the next five years, with a main aim to increase R&D activities in the country. The new investment will include...
Novartis to break ground for R&D center in Beijing
By Alaric DeArment BEIJING (Nov. 4) Novartis will spend $1 billion to build the largest pharmaceutical research and development institute in China, the company announced. The Swiss drug maker said the Novartis Institute of...
Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China
Additional USD 250 million invested in advanced technical R&D and manufacturing facility opening in Changshu, furthering economic development of Jiangsu province and Suzhou city 04 Nov 2009 - Novartis announced a USD 1 billion...
Novartis Seeks to Make China One Its Top Three Global Markets (at Seeking Alpha)
by: ChinaBio Today November 04, 2009 | about: ) of Switzerland will begin a five-year, $1 billion China initiative with two aims: the company will dramatically increase its investment in its China R&D facility, and it will seek...
Novartis to invest billion dollars in China
Geneva (AFP) Nov 3, 2009 - Swiss pharmaceutical group Novartis said Tuesday that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.
Novartis Seeks to Make China One of Its Top Three Global Markets
ChinaBio Today submits: Novartis (NYSE: NVS ) of Switzerland will begin a five-year, $1 billion China initiative with two aims: the company will dramatically increase its investment in its China R&D facility, and it will seek...
Novartis To Invest $1 Billion in China R&D Institute
Novartis (Basel, Switzerland) plans to invest $1 billion over the next five years to increase research and development (R&D) activities in China, including a significant expansion of The Novartis Institute of BioMedical...
Related categories
International Editions
English - US | English - UK | Deutsch | Français | Español - España | Português - Portugal | Italiano | Čeština | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese) | Español - México | Português - Brasil | 한국어 (Korean) | English - India
